Immuno-Oncology (IO) 360 is a conference dedicated to the latest data impacting immuno-oncology combinations and patient treatment.
Immuno-Oncology (IO) 360 covers topics such as:
- Translational Science & Emerging Biomarkers
- Discovery/Preclinical Science
- Cell Therapy & Bispecifics
- IO Novel Technologies
- Business Aspects
- Clinical Operations
- Clinical Developments
Immuno-Oncology (IO) 360 is intended for:
- Academia & Research Organizations
- Large Pharma /Biopharma /Biotech
- Investment Community
- Solution Providers